188 related articles for article (PubMed ID: 22963597)
1. Differential uptake of chemically modified cowpea mosaic virus nanoparticles in macrophage subpopulations present in inflammatory and tumor microenvironments.
Agrawal A; Manchester M
Biomacromolecules; 2012 Oct; 13(10):3320-6. PubMed ID: 22963597
[TBL] [Abstract][Full Text] [Related]
2. Endocytic uptake pathways utilized by CPMV nanoparticles.
Plummer EM; Manchester M
Mol Pharm; 2013 Jan; 10(1):26-32. PubMed ID: 22905759
[TBL] [Abstract][Full Text] [Related]
3. Interaction of Cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo.
Gonzalez MJ; Plummer EM; Rae CS; Manchester M
PLoS One; 2009 Nov; 4(11):e7981. PubMed ID: 19956734
[TBL] [Abstract][Full Text] [Related]
4. PEGylated viral nanoparticles for biomedicine: the impact of PEG chain length on VNP cell interactions in vitro and ex vivo.
Steinmetz NF; Manchester M
Biomacromolecules; 2009 Apr; 10(4):784-92. PubMed ID: 19281149
[TBL] [Abstract][Full Text] [Related]
5. Injectable Hydrogel Containing Cowpea Mosaic Virus Nanoparticles Prevents Colon Cancer Growth.
Nkanga CI; Steinmetz NF
ACS Biomater Sci Eng; 2022 Jun; 8(6):2518-2525. PubMed ID: 35522951
[TBL] [Abstract][Full Text] [Related]
6. Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells.
Destito G; Yeh R; Rae CS; Finn MG; Manchester M
Chem Biol; 2007 Oct; 14(10):1152-62. PubMed ID: 17961827
[TBL] [Abstract][Full Text] [Related]
7. Utilizing Viral Nanoparticle/Dendron Hybrid Conjugates in Photodynamic Therapy for Dual Delivery to Macrophages and Cancer Cells.
Wen AM; Lee KL; Cao P; Pangilinan K; Carpenter BL; Lam P; Veliz FA; Ghiladi RA; Advincula RC; Steinmetz NF
Bioconjug Chem; 2016 May; 27(5):1227-35. PubMed ID: 27077475
[TBL] [Abstract][Full Text] [Related]
8. Viral nanoparticles associate with regions of inflammation and blood brain barrier disruption during CNS infection.
Shriver LP; Koudelka KJ; Manchester M
J Neuroimmunol; 2009 Jun; 211(1-2):66-72. PubMed ID: 19394707
[TBL] [Abstract][Full Text] [Related]
9. In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer.
Lizotte PH; Wen AM; Sheen MR; Fields J; Rojanasopondist P; Steinmetz NF; Fiering S
Nat Nanotechnol; 2016 Mar; 11(3):295-303. PubMed ID: 26689376
[TBL] [Abstract][Full Text] [Related]
10. Hybrid virus-polymer materials. 1. Synthesis and properties of PEG-decorated cowpea mosaic virus.
Raja KS; Wang Q; Gonzalez MJ; Manchester M; Johnson JE; Finn MG
Biomacromolecules; 2003; 4(3):472-6. PubMed ID: 12741758
[TBL] [Abstract][Full Text] [Related]
11. Infusion of imaging and therapeutic molecules into the plant virus-based carrier cowpea mosaic virus: cargo-loading and delivery.
Yildiz I; Lee KL; Chen K; Shukla S; Steinmetz NF
J Control Release; 2013 Dec; 172(2):568-78. PubMed ID: 23665254
[TBL] [Abstract][Full Text] [Related]
12. Cowpea Mosaic Virus Nanoparticles and Empty Virus-Like Particles Show Distinct but Overlapping Immunostimulatory Properties.
Wang C; Beiss V; Steinmetz NF
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375592
[TBL] [Abstract][Full Text] [Related]
13. Anti-atherogenic effect of trivalent chromium-loaded CPMV nanoparticles in human aortic smooth muscle cells under hyperglycemic conditions in vitro.
Ganguly R; Wen AM; Myer AB; Czech T; Sahu S; Steinmetz NF; Raman P
Nanoscale; 2016 Mar; 8(12):6542-54. PubMed ID: 26935414
[TBL] [Abstract][Full Text] [Related]
14. Cowpea Mosaic Virus Outperforms Other Members of the Secoviridae as In Situ Vaccine for Cancer Immunotherapy.
Beiss V; Mao C; Fiering SN; Steinmetz NF
Mol Pharm; 2022 May; 19(5):1573-1585. PubMed ID: 35333531
[TBL] [Abstract][Full Text] [Related]
15. In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma.
Murray AA; Wang C; Fiering S; Steinmetz NF
Mol Pharm; 2018 Sep; 15(9):3700-3716. PubMed ID: 29798673
[TBL] [Abstract][Full Text] [Related]
16. Development of viral nanoparticles for efficient intracellular delivery.
Wu Z; Chen K; Yildiz I; Dirksen A; Fischer R; Dawson PE; Steinmetz NF
Nanoscale; 2012 Jun; 4(11):3567-76. PubMed ID: 22508503
[TBL] [Abstract][Full Text] [Related]
17. Hybrid assembly of CPMV viruses and surface characteristics of different mutants.
Portney NG; Destito G; Manchester M; Ozkan M
Curr Top Microbiol Immunol; 2009; 327():59-69. PubMed ID: 19198570
[TBL] [Abstract][Full Text] [Related]
18. Metastatic Colon Cancer Treatment Using S100A9-Targeted Cowpea Mosaic Virus Nanoparticles.
Chung YH; Volckaert BA; Steinmetz NF
Biomacromolecules; 2022 Dec; 23(12):5127-5136. PubMed ID: 36375170
[TBL] [Abstract][Full Text] [Related]
19. S100A9-Targeted Cowpea Mosaic Virus as a Prophylactic and Therapeutic Immunotherapy against Metastatic Breast Cancer and Melanoma.
Chung YH; Park J; Cai H; Steinmetz NF
Adv Sci (Weinh); 2021 Nov; 8(21):e2101796. PubMed ID: 34519180
[TBL] [Abstract][Full Text] [Related]
20. Inactivated Cowpea Mosaic Virus in Combination with OX40 Agonist Primes Potent Antitumor Immunity in a Bilateral Melanoma Mouse Model.
Koellhoffer EC; Mao C; Beiss V; Wang L; Fiering SN; Boone CE; Steinmetz NF
Mol Pharm; 2022 Feb; 19(2):592-601. PubMed ID: 34978197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
